‘We’re all epidemiologists now’ – Bidwells latest podcast

News of AstraZeneca’s recent Covid-19 partnership agreement with the University of Oxford has echoed around the world. The deal would see the Cambridge-based pharmaceutical giant producing billions of doses of a vaccine currently being trialled at The Jenner Institute in Oxford, at no profit, and effectively bring an end to the global crisis. Meanwhile in Milton Keynes the UK ‘mega lab’, the Lighthouse Laboratory, recently completed its 500,000th Coronavirus test.

This crisis has shown how effectively the UK life sciences industry collaborates, with its response to the global pandemic the fastest in the world. But as marketing opportunities for the UK and the Oxford-Cambridge Arc go, they don’t come much bigger. With epidemiology leading the news each day, we ask how should business and political leaders in Oxford, Cambridge and Milton Keynes be building on the public’s new awareness of the importance of scientific research to both our health and the UK economy?

Listen to hear from Astra Zenenca’s Andy Williams, Chloe French from Bidwells and Advanced Oxford’s MD Sarah Haywood in conversation.

 

Click here to listen to the podcast

Recent news

Times Higher Education article – female academic founders

Times Higher Education article – female academic founders

Advanced Oxford member and collaborator considers the role of investors in supporting female academic founders Simonetta Manfredi is a professor of equality and diversity management, and the Director for Research, Innovation and Enterprise at Oxford Brookes...

read more
Amano Enzyme establishes new European hub at Milton Park

Amano Enzyme establishes new European hub at Milton Park

The world’s leading manufacturer of speciality enzymes, has established its new Europe, Middle East and Africa (EMEA) hub at Milton Park. Amano Enzymes, the Japanese biotechnology company - which uses its enzymes to boost the flavour, texture, colour, digestion and...

read more
Next step in expansion of The Oxford Science Park

Next step in expansion of The Oxford Science Park

Detailed planning application submitted for Plot 27 New R&D building part of >500,000 sq ft expansion plan as the Park innovation ecosystem grows. The Oxford Science Park (TOSP), one of Europe’s leading locations for science and technology companies, is...

read more
Loading...